Arthur JC, Jobin C (2013) The complex interplay between inflammation, the microbiota and colorectal cancer. Gut microbes;4(3):253-8. https://doi.org/10.4161/gmic.24220
Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ et al (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123. https://doi.org/10.1126/science.1224820
Article CAS PubMed PubMed Central Google Scholar
Bardou M, Barkun AN, Martel M (2013) Obesity and colorectal cancer. Gut 62(6):933–947. https://doi.org/10.1136/gutjnl-2013-304701
Article CAS PubMed Google Scholar
Bardou M, Rouland A, Martel M, Loffroy R, Barkun AN, Chapelle N (2022) Review article: obesity and colorectal cancer. Aliment Pharmacol Ther 56(3):407–418. https://doi.org/10.1111/apt.17045
Article CAS PubMed Google Scholar
Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B et al (2014a) Colonization of the human gut by E. Coli and colorectal cancer risk. Clin Cancer Res 20(4):859–867. https://doi.org/10.1158/1078-0432.CCR-13-1343
Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B et al (2014b) Colonization of the human gut by E. Coli and colorectal cancer risk. Clin cancer Research: Official J Am Association Cancer Res 20(4):859–867. https://doi.org/10.1158/1078-0432.Ccr-13-1343
Boyer HW, Roulland-Dussoix D (1969) A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol 41(3):459–472. https://doi.org/10.1016/0022-2836(69)90288-5
Article CAS PubMed Google Scholar
Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A et al (2013) High prevalence of mucosa-associated E. Coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE 8(2):e56964. https://doi.org/10.1371/journal.pone.0056964
Article CAS PubMed PubMed Central Google Scholar
Canizalez-Roman A, Reina-Reyes JE, Angulo-Zamudio UA, Geminiano-Martinez EE, Flores-Carrillo AF, Garcia-Matus RR et al (2021a) Prevalence of Cyclomodulin-Positive E. coli and Klebsiella spp. Strains in Mexican Patients with Colon Diseases and Antimicrobial Resistance. Pathogens;11(1). https://doi.org/10.3390/pathogens11010014
Canizalez-Roman A, Reina-Reyes JE, Angulo-Zamudio UA, Geminiano-Martínez EE, Flores-Carrillo AF, García-Matus RR et al (2021b) Prevalence of Cyclomodulin-Positive E. coli and Klebsiella spp. Strains in Mexican Patients with Colon Diseases and Antimicrobial Resistance. Pathogens;11(1). https://doi.org/10.3390/pathogens11010014
Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP et al (2009) Crohn’s disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 206(10):2179–2189. https://doi.org/10.1084/jem.20090741
Article CAS PubMed PubMed Central Google Scholar
Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci USA 107(12):5540–5544. https://doi.org/10.1073/pnas.0912675107
Article PubMed PubMed Central Google Scholar
Chen J, Pitmon E, Wang K (2017) Microbiome, inflammation and colorectal cancer. Semin Immunol 32:43–53. https://doi.org/10.1016/j.smim.2017.09.006
Article CAS PubMed Google Scholar
Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L et al (2014) Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 63(12):1932–1942. https://doi.org/10.1136/gutjnl-2013-305257
Article CAS PubMed Google Scholar
Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède JP (2010) Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 107(25):11537–11542. https://doi.org/10.1073/pnas.1001261107
Article PubMed PubMed Central Google Scholar
DeLira-Bustillos N, Angulo-Zamudio UA, Leon-Sicairos N, Flores-Villaseñor H, Velazquez-Roman J, Tapia-Pastrana G et al (2024) Distribution and virulence of Escherichia coli harboring cyclomodulins and supplementary virulence genes isolates from clinical and environmental samples. Microb Pathog 190:106634. https://doi.org/10.1016/j.micpath.2024.106634
Article CAS PubMed Google Scholar
Gomes TA, Elias WP, Scaletsky IC, Guth BE, Rodrigues JF, Piazza RM et al (2016) Diarrheagenic Escherichia coli. Brazilian journal of microbiology: [publication of the Brazilian Society for Microbiology];47 suppl 1. Suppl 13–30. https://doi.org/10.1016/j.bjm.2016.10.015
Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S et al (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15(2):103–113. https://doi.org/10.1016/j.ccr.2009.01.001
Article CAS PubMed PubMed Central Google Scholar
Hooper LV, Bry L, Falk PG, Gordon JI (1998) Host–microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. BioEssays 20(4):336–343
Article CAS PubMed Google Scholar
Hyun YS, Han DS, Lee AR, Eun CS, Youn J, Kim HY (2012) Role of IL-17A in the development of colitis-associated cancer. Carcinogenesis;33(4):931-6. https://doi.org/10.1093/carcin/bgs106
Jubelin G, Chavez CV, Taieb F, Banfield MJ, Samba-Louaka A, Nobe R et al (2009) Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS ONE 4(3):e4855. https://doi.org/10.1371/journal.pone.0004855
Article CAS PubMed PubMed Central Google Scholar
Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC et al (2012) Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336(6086):1325–1329. https://doi.org/10.1126/science.1222195
Article CAS PubMed PubMed Central Google Scholar
Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2(2):123–140. https://doi.org/10.1038/nrmicro818
Article CAS PubMed Google Scholar
Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J et al (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128(4):891–906. https://doi.org/10.1053/j.gastro.2005.02.009
Article CAS PubMed Google Scholar
Kitakata H, Nemoto-Sasaki Y, Takahashi Y, Kondo T, Mai M, Mukaida N (2002) Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res 62(22):6682–6687
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K (2016) Body fatness and Cancer–viewpoint of the IARC Working Group. N Engl J Med 375(8):794–798. https://doi.org/10.1056/NEJMsr1606602
Article PubMed PubMed Central Google Scholar
Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC et al (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2(2):119–129
Article CAS PubMed Google Scholar
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436–444. https://doi.org/10.1038/nature07205
Article CAS PubMed Google Scholar
Marchès O, Ledger TN, Boury M, Ohara M, Tu X, Goffaux F et al (2003) Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 50(5):1553–1567. https://doi.org/10.1046/j.1365-2958.2003.03821.x
Article CAS PubMed Google Scholar
Martinson JNV, Walk ST (2020) Escherichia coli Residency in the gut of healthy human adults. EcoSal Plus 9(1). https://doi.org/10.1128/ecosalplus.ESP-0003-2020
Morgan RN, Saleh SE, Farrag HA, Aboulwafa MM (2022) Bacterial cyclomodulins: types and roles in carcinogenesis. Crit Rev Microbiol 48(1):42–66. https://doi.org/10.1080/1040841x.2021.1944052
Article CAS PubMed Google Scholar
Nishikubo S, Ohara M, Ueno Y, Ikura M, Kurihara H, Komatsuzawa H et al (2003) An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem 278(50):50671–50681. https://doi.org/10.1074/jbc.M305062200
Comments (0)